What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee.
about
Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injectionMetabolomic assessment of embryo viabilityDynamics and ethics of comprehensive preimplantation genetic testing: a review of the challengesWhole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011.The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing.ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008.OMICS: Current and future perspectives in reproductive medicine and technologyPreimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?Preimplantation genetic diagnosis: state of the art 2011.ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009.Singling out genetic disorders and disease.The 'thousand-dollar genome': an ethical exploration.Blood pressure and anthropometrics of 4-y-old children born after preimplantation genetic screening: follow-up of a unique, moderately sized, randomized controlled trial.Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles.Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results.New array approaches to explore single cells genomesMultiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation.Preimplantation genetic screening for all 24 chromosomes by microarray comparative genomic hybridization significantly increases implantation rates and clinical pregnancy rates in patients undergoing in vitro fertilization with poor prognosis.New protocol based on massive parallel sequencing for aneuploidy screening of preimplantation human embryos.Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women.A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practiceThe impact of patient preselection on reported IVF outcomes.Discrepant diagnosis rate of array comparative genomic hybridization in thawed euploid blastocysts.Preimplantation genetic screening (PGS) with Comparative genomic hybridization (CGH) following day 3 single cell blastomere biopsy markedly improves IVF outcomes while lowering multiple pregnancies and miscarriages.Preimplantation genetic diagnosis guided by single-cell genomics.Delayed childbearing: effects on fertility and the outcome of pregnancy.A methodological overview on molecular preimplantation genetic diagnosis and screening: a genomic future?Twenty years of Cochrane reviews in menstrual disorders and subfertility.Polar bodies in assisted reproductive technology: current progress and future perspectives.How should we choose the 'best' embryo? A commentary on behalf of the British Fertility Society and the Association of Clinical Embryologists.Elective Single Embryo Transfer: an update to UK Best Practice Guidelines.Preimplantation genetic screening.Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences?Karyomapping and how is it improving preimplantation genetics?When and how should new technology be introduced into the IVF laboratory?[Preimplantation diagnosis--PID: preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)].Production of offspring after sperm chromosome screening: an experiment using the mouse model.Preimplantation genetic diagnosis: an update on current technologies and ethical considerations.Vorsprung durch Technik: On biotechnology, bioethics, and its beneficiaries.
P2860
Q24244735-D065458A-E0B8-48C7-AF66-FEC88FCB0FCDQ26822576-74B2D0FD-629E-4759-A35B-D9AB3B47C26FQ28286723-161D3173-6D7C-49D2-9104-6B1366736D96Q30391597-9954DF95-EB88-4037-B9EF-25937A1F0D0CQ30970981-B0846EF8-62E6-45DC-81E7-18A06B12069EQ33592827-BCC2B032-81ED-47F5-A54B-70C26CB8ECE5Q33683144-F0338D4A-B7FD-499D-9A55-0A3975C4AD96Q34113055-73702FB5-6E94-4DF5-A7F5-A5BADB7BADA4Q34199329-E9D407B5-D773-4403-99E8-BF360D73A5BAQ34199663-CD0F7961-66B7-4DA2-AD6C-106A6C044653Q34263818-1C073C67-0D75-4D68-A5B5-62F6F7B2768CQ34334104-14719EAA-24DF-4FE0-8144-26F1D6137D4CQ34724819-14ECD365-BFFC-4E76-879C-387B6BC163DBQ34944766-C72A0801-7E7C-4439-8A89-86C4C784FA67Q35357388-D9A3BF3C-CF72-4A50-95B6-AA536F43AA26Q35389273-5E0E340E-1C11-4E81-9F2B-E785B6CE0D91Q35887436-7B4B1C9F-890F-4427-B742-A1381000AD70Q36035686-2BB0DA7C-9204-4AD0-8F26-C9BF71F36E59Q36068679-6B75EE32-5823-41EE-9EC8-20B8A0EB9B6AQ36342048-1F4E7F35-6894-4C88-8516-0A31276528E5Q36390581-615BDC48-D354-4FB7-83E6-BD40E94D06A2Q36434649-A7C4173A-F8B9-48A6-A7DB-4DCE06C52304Q36758994-8972341B-9343-40AD-8200-7B305A4AA837Q37059959-A83543A6-6854-47DB-8F57-1142332C785AQ37300095-F6808A78-ED9B-4259-AF78-0C6D2A016CB7Q37691155-4790FFEE-74C0-45E2-A28E-BE0BB286EB59Q37828026-DA25A209-4527-40C4-A8A7-0555092C396EQ38031577-E58F393F-9001-430A-A340-8661C3591BDFQ38132735-F5FC19B0-3B73-4059-9539-A74A731A711AQ38282802-B32F3BD2-B56B-42AA-A733-482866FCA5D2Q38575047-7A8A4B18-C987-444F-9F88-23D3E7B32519Q38590592-B34778AF-DDEB-4AF1-B948-E1035E31940BQ38671062-FFF98E66-6EC1-4CEB-8DDB-F9C7E5727A94Q38864772-A7C05F2D-EF55-406A-8C6B-2F142EEE0D4BQ39274880-F673AE1B-5C09-4039-8BD2-114982F15E8BQ41606774-6CF0D6F8-677E-4EC1-9B9F-81F3A527014BQ44400550-980AA0A2-62C8-4D7E-9021-38B1DF4A5EE3Q46297164-345184DB-3EE6-4E0F-9BA1-F400CBD4ED76Q47120861-EA762CBA-E752-4F25-ADEB-8231D70F7822Q47311284-1FBFA4EB-33A3-4D6E-8B4F-1B0DA251DA2F
P2860
What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
What next for preimplantation ...... Consortium Steering Committee.
@en
What next for preimplantation genetic screening
@nl
type
label
What next for preimplantation ...... Consortium Steering Committee.
@en
What next for preimplantation genetic screening
@nl
prefLabel
What next for preimplantation ...... Consortium Steering Committee.
@en
What next for preimplantation genetic screening
@nl
P2093
P2860
P356
P1433
P1476
What next for preimplantation ...... Consortium Steering Committee.
@en
P2093
Celine Moutou
Edith Coonen
Francesco Fiorentino
Gary Harton
Joanne Traeger-Synodinos
Joep Geraedts
Joyce Harper
Katerina Vesela
Martine De Rycke
Pam Renwick
P2860
P304
P356
10.1093/HUMREP/DEP476
P407
P577
2010-02-02T00:00:00Z